NCT00759148View on ClinicalTrials.gov

Moxifloxacin AF Ophthalmic Solution for Treatment of Bacterial Conjunctivitis

PHASE3CompletedINTERVENTIONAL

Enrollment

1,179

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions

Bacterial Conjunctivitis

Interventions

DRUG

Moxifloxacin Alternative Formulation (AF) Ophthalmic Solution 0.5%

Eye drops

OTHER

Moxifloxacin AF Vehicle

Inactive ingredients used as a placebo for masking purposes

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Alcon Research

INDUSTRY